Additional information
White powder
1365545-42-1
ACI-043806
(4S,4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trißuoromethyl)phenyl]-4-chloro-4a,6adimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4S,4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trißuoromethyl)phenyl]-4-chloro-4a,6adimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
275.9-277.9°C
C27H31ClF6N2O2
564.99
cold Condition
-20°C
N-[2,5-Bis(trifluoromethyl)phenyl]-1?-chloro-3-oxo-4-aza-5?-androstane-17?-carboxamide
5-alpha reductase inhibitor






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)